Skip to main content
. 2019 Aug 1;11(8):1099. doi: 10.3390/cancers11081099

Figure 3.

Figure 3

ARFL, ARV7 and PSMA expression in EpCAM+ CTCs of mCRPC patients at progressive disease (PD): (a) ARFL and ARV7 expression and (b) PSMA and ARFL expression. The number in each bar refers to the number of patients with the indicated CTC phenotype. The total number of analyzed patients with CTC-positive blood samples at PD was 19.